Literature DB >> 30141701

Clostridium butyricum protects the epithelial barrier by maintaining tight junction protein expression and regulating microflora in a murine model of dextran sodium sulfate-induced colitis.

Hui Li1, Yi Gong1, Ying Xie1, Qian Sun1, Yan Li1.   

Abstract

OBJECTIVE: To investigate the protective effects of Clostridium butyricum on the epithelial barrier in dextran sodium sulfate (DSS)-induced colitis.
METHODS: Eight-week-old BALB/c mice were divided into a healthy control group and DSS-induced groups, including negative control (normal saline), 5-aminosalicylic acid (5-ASA), C. butyricum group, and 5-ASA + C. butyricum groups. Colitis was induced by 5% DSS ad libitum for 7 d. We assessed the disease activity index (DAI), histological grading, and ultrastructural changes by transmission electron microscopy. Stools were collected for bacterial microflora analysis. Tight junction (TJ) proteins, including claudin-1, claudin-2, occluding, and zonula occludens-1, were detected by immunohistochemical staining and western blot. We also assessed NF-κB and cytokines, including IL-1β, IL-13, and IL-10, by western blot.
RESULTS: C. butyricum decreased DAI and histological injury scores in DSS-induced mice, and repaired the damaged structure of TJs. Moreover, C. butyricum exerted its regulatory effect on fecal microflora by increasing and decreasing the growth of Lactobacillus spp. and Enterococcus spp., respectively, in the colon lumen. Expression levels of claudin-1, occludin and zonula occludens-1 were also elevated by the administration of C. butyricum. In addition, C. butyricum increased the expression of the anti-inflammatory cytokine, IL-10, and decreased levels of pro-inflammatory cytokines, including IL-1β, TNF, and IL-13, as well as NF-κB. Moreover, the beneficial effects of C. butyricum combined with 5-ASA were superior to treatment with C. butyricum only.
CONCLUSION: In a mouse model of ulcerative colitis (UC), C. butyricum exerted a protective effect on the epithelial barrier by regulating microflora, maintaining the expression of TJ proteins and exerting immunoregulatory effects.

Entities:  

Keywords:  Dextra sodium sulfate; epithelial barrier; microflora; tight junction; ulcerative colitis

Mesh:

Substances:

Year:  2018        PMID: 30141701     DOI: 10.1080/00365521.2016.1192678

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  9 in total

1.  DNMT3a-Mediated Enterocyte Barrier Dysfunction Contributes to Ulcerative Colitis via Facilitating the Interaction of Enterocytes and B Cells.

Authors:  Bo Cheng; Ai-Mei Rong; Wenlu Li; Xiuqian Bi; Xinguang Qiu
Journal:  Mediators Inflamm       Date:  2022-05-06       Impact factor: 4.529

Review 2.  New Advances in Improving Bone Health Based on Specific Gut Microbiota.

Authors:  Qihui Yan; Liping Cai; Weiying Guo
Journal:  Front Cell Infect Microbiol       Date:  2022-07-04       Impact factor: 6.073

3.  Keratin 1 maintains the intestinal barrier in ulcerative colitis.

Authors:  Jing Wu; Junkun Niu; Maojuan Li; Yinglei Miao
Journal:  Genes Genomics       Date:  2021-09-25       Impact factor: 1.839

4.  Clostridium butyricum inhibits the progression of colorectal cancer and alleviates intestinal inflammation via the myeloid differentiation factor 88 (MyD88)-nuclear factor-kappa B (NF-κB) signaling pathway.

Authors:  Mingyao Zhou; Wei Yuan; Bing Yang; Wei Pei; Jie Ma; Qiang Feng
Journal:  Ann Transl Med       Date:  2022-04

5.  The Effect of Clostridium butyricum on Gut Microbiota, Immune Response and Intestinal Barrier Function During the Development of Necrotic Enteritis in Chickens.

Authors:  Ting Huang; Xin-Yu Peng; Biao Gao; Qi-Lin Wei; Rong Xiang; Ming-Gui Yuan; Zhi-Hong Xu
Journal:  Front Microbiol       Date:  2019-10-11       Impact factor: 5.640

6.  Oral administration of Lactobacillus plantarum 06CC2 prevents experimental colitis in mice via an anti‑inflammatory response.

Authors:  Akihito Tanaka; Shuji Kanmura; Yuko Morinaga; Katsuto Kawabata; Shiho Arima; Fumisato Sasaki; Yuichirou Nasu; Shiroh Tanoue; Shinichi Hashimoto; Masahiko Takeshita; Shiro Takeda; Akio Ido
Journal:  Mol Med Rep       Date:  2020-01-09       Impact factor: 2.952

7.  The effect of dietary supplementation with Clostridium butyricum on the growth performance, immunity, intestinal microbiota and disease resistance of tilapia (Oreochromis niloticus).

Authors:  Hongqin Li; Ying Zhou; Huayun Ling; Li Luo; Desheng Qi; Lin Feng
Journal:  PLoS One       Date:  2019-12-09       Impact factor: 3.240

8.  Clostridium butyricum therapy for mild-moderate Clostridioides difficile infection and the impact of diabetes mellitus.

Authors:  Jen-Chieh Lee; Chun-Wei Chiu; Pei-Jane Tsai; Ching-Chi Lee; I-Hsiu Huang; Wen-Chien Ko; Yuan-Pin Hung
Journal:  Biosci Microbiota Food Health       Date:  2021-11-03

Review 9.  Overview of the Importance of Biotics in Gut Barrier Integrity.

Authors:  Aleksandra Maria Kocot; Elżbieta Jarocka-Cyrta; Natalia Drabińska
Journal:  Int J Mol Sci       Date:  2022-03-07       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.